Psych Disorders May Reduce Response to CGRPs for Migraine
Patients with migraine are less likely to respond to the new CGRP monoclonal antibody preventive treatments, if they have certain psychiatric disorders, new research shows.
Comunidad Autonoma De Cataluna Fabrizio Vernieri Lars Edvinsson Sara Bottiroli Lund University Hospital University Of Pavia
Source: medscape.com